{
  "disease_name": "Canavan disease",
  "orpha_code": "141",
  "drugs": [
    {
      "name": "Recombinant adeno-associated virus Olig001 containing human aspartoacylase cDNA",
      "substance_url": "/en/drug/substance/638733?name=141&mode=orpha&region=&status=all",
      "substance_id": "638733",
      "regulatory_url": "/en/drug/regulatory/638735?name=141&mode=orpha&region=",
      "regulatory_id": "638735",
      "orpha_substance_code": "ORPHA:141",
      "details": [
        "Recombinant adeno-associated virus Olig001 containing human aspartoacylase cDNA(Medicinal product                        - 09/12/2022)Disease(s) concernedORPHA:141 Canavan disease",
        "Recombinant adeno-associated virus Olig001 containing human aspartoacylase cDNA(Medicinal product                        - 09/12/2022)",
        "(Medicinal product                        - 09/12/2022)",
        "Disease(s) concernedORPHA:141 Canavan disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/638733?name=141&mode=orpha&region=&status=all",
          "text": "Recombinant adeno-associated virus Olig001 containing human aspartoacylase cDNA",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/141",
          "text": "ORPHA:141 Canavan disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/638735?name=141&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated virus serotype 9 containing the human ASPA gene",
      "substance_url": "/en/drug/substance/589288?name=141&mode=orpha&region=&status=all",
      "substance_id": "589288",
      "regulatory_url": "/en/drug/regulatory/589289?name=141&mode=orpha&region=",
      "regulatory_id": "589289",
      "orpha_substance_code": "ORPHA:141",
      "details": [
        "Adeno-associated virus serotype 9 containing the human ASPA gene(Medicinal product                        - 04/06/2020)Disease(s) concernedORPHA:141 Canavan disease",
        "Adeno-associated virus serotype 9 containing the human ASPA gene(Medicinal product                        - 04/06/2020)",
        "(Medicinal product                        - 04/06/2020)",
        "Disease(s) concernedORPHA:141 Canavan disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/589288?name=141&mode=orpha&region=&status=all",
          "text": "Adeno-associated virus serotype 9 containing the human ASPA gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/141",
          "text": "ORPHA:141 Canavan disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/589289?name=141&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant adeno-associated virus containing human ASPA cDNA (rAAV-Olig001-ASPA)",
      "substance_url": "/en/drug/substance/641663?name=141&mode=orpha&region=&status=all",
      "substance_id": "641663",
      "regulatory_url": "/en/drug/regulatory/641664?name=141&mode=orpha&region=",
      "regulatory_id": "641664",
      "orpha_substance_code": "ORPHA:141",
      "details": [
        "Recombinant adeno-associated virus containing human ASPA cDNA (rAAV-Olig001-ASPA)(Medicinal product                        - 17/02/2022)Disease(s) concernedORPHA:141 Canavan disease",
        "Recombinant adeno-associated virus containing human ASPA cDNA (rAAV-Olig001-ASPA)(Medicinal product                        - 17/02/2022)",
        "(Medicinal product                        - 17/02/2022)",
        "Disease(s) concernedORPHA:141 Canavan disease",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/641663?name=141&mode=orpha&region=&status=all",
          "text": "Recombinant adeno-associated virus containing human ASPA cDNA (rAAV-Olig001-ASPA)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/141",
          "text": "ORPHA:141 Canavan disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/641664?name=141&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:01:06.351628",
  "run_number": 1,
  "total_drugs_found": 3,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Canavan+disease&orphaCode=141&name=141&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Canavan disease",
    "orphaCode": "141",
    "name": "141",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}